These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34099367)

  • 121. Dose escalation and associated costs in biologic treatment of psoriasis based on real-world data.
    Bagel J; Glick B; Wu JJ; Chopra I; Song X; Brouillette M; Mendelsohn A; Rozzo S; Han G
    J Med Econ; 2021; 24(1):782-791. PubMed ID: 34107834
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Enthesitis in Psoriatic Arthritis, the Sonographic Perspective.
    Smerilli G; Di Matteo A; Cipolletta E; Grassi W; Filippucci E
    Curr Rheumatol Rep; 2021 Aug; 23(9):75. PubMed ID: 34427783
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety.
    Kolbinger F; Di Padova F; Deodhar A; Hawkes JE; Huppertz C; Kuiper T; McInnes IB; Ritchlin CT; Rosmarin D; Schett G; Carballido JM; Häusermann P; Calonder C; Vogel B; Rondeau JM; Bruin G
    Pharmacol Ther; 2022 Jan; 229():107925. PubMed ID: 34171337
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up.
    Papp KA; Lebwohl MG; Puig L; Ohtsuki M; Beissert S; Zeng J; Rubant S; Sinvhal R; Zhao Y; Soliman AM; Alperovich G; Leonardi C
    Br J Dermatol; 2021 Dec; 185(6):1135-1145. PubMed ID: 34157132
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis.
    Glintborg B; Jensen DV; Terslev L; Pfeiffer Jensen M; Hendricks O; Østergaard M; Engel S; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Nørgaard Agerbo J; Ziegler C; Hetland ML
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI3-SI12. PubMed ID: 34146099
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study.
    Lorenzin M; Ortolan A; Cozzi G; Calligaro A; Favaro M; Del Ross T; Doria A; Ramonda R
    Clin Rheumatol; 2021 Nov; 40(11):4569-4580. PubMed ID: 34136971
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Patterns of Comorbidities in Psoriasis Patients: A Cross-Sectional Study.
    Alajmi RS; Alamoudi SM; Alabbasi AA; Alwagdani A; Alraddadi AA; Alamri A
    Cureus; 2021 May; 13(5):e14907. PubMed ID: 34113517
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2.
    Reich K; Gordon KB; Strober BE; Armstrong AW; Miller M; Shen YK; You Y; Han C; Yang YW; Foley P; Griffiths CEM
    Br J Dermatol; 2021 Dec; 185(6):1146-1159. PubMed ID: 34105767
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Proceedings of the GRAPPA 2022 Executive Retreat.
    Ng BCK; Jadon D; Adebajo A; Ayan G; Duffin KC; Chandran V; Coates LC; D'Agostino MA; de Vlam K; Deodhar A; Eder L; Garg A; Gladman DD; Goel N; Gottlieb AB; Husni ME; Katz A; Kavanaugh A; Lubrano E; Mease PJ; Merola JF; Nash P; Ogdie A; Pennington SR; Perez-Chada LM; Proft F; Rosen CF; Savage L; Goldenstein-Schainberg C; Siebert S; Soriano ER; Steinkoenig I; Tillett W; Armstrong AW; FitzGerald O
    J Rheumatol; 2023 Nov; 50(Suppl 2):71-77. PubMed ID: 37527861
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey.
    Armstrong AW; Bohannan B; Mburu S; Coates LC; Ogdie A; Alarcon I; Kasparek T; Frade S; Barrio SF; Augustin M
    Dermatology; 2023; 239(4):621-634. PubMed ID: 37075723
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Horizon scan: State-of-the-art therapeutics for psoriatic arthritis.
    Hutton J; Mease P; Jadon D
    Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101809. PubMed ID: 36567224
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations.
    Jadon DR; Corp N; van der Windt DA; Coates LC; Soriano ER; Kavanaugh A; Raine T; Rieder F; Siebert S; Zummer M; Schwartzman S; Rosenbaum JT; Michelsen B; Laxminarayan R; Wu D; Gupta L; Ng B; Jethwa H; De Windt N; Gudu T; Hutton J; O'Sullivan D; Luchetti MM; Stoll M; Singh JA; Peluso R; Rademacher J; Husni ME
    J Rheumatol; 2023 Mar; 50(3):438-450. PubMed ID: 36455946
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Consensus-based recommendations on the diagnosis, referral and clinical management of patients with psoriatic arthritis.
    Al Rayes H; Alazmi M; Attar S; Alderaan K; Alghamdi M; Alghanim N; Alhazmi A; Alkhadhrawi N; Almohideb M; Alzahrani Z; Bedaiwi M; Halabi H
    Rheumatol Int; 2022 Mar; 42(3):391-401. PubMed ID: 34716785
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Should the presence of psoriatic arthritis change how we manage psoriasis?
    Chan WH; Singh R; Feldman SR
    J Dermatolog Treat; 2021 Dec; 32(8):863-865. PubMed ID: 34515604
    [No Abstract]   [Full Text] [Related]  

  • 135. Translational Research Studies Unraveling the Origins of Psoriatic Arthritis: Moving Beyond Skin and Joints.
    Bolt JW; van Ansenwoude CMJ; Hammoura I; van de Sande MG; van Baarsen LGM
    Front Med (Lausanne); 2021; 8():711823. PubMed ID: 34485340
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Targeted Therapies in Axial Psoriatic Arthritis.
    Floris A; Congia M; Chessa E; Angioni MM; Piga M; Cauli A
    Front Genet; 2021; 12():689984. PubMed ID: 34262600
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Psoriatic Dactylitis: Current Perspectives and New Insights in Ultrasonography and Magnetic Resonance Imaging.
    Girolimetto N; Giovannini I; Crepaldi G; De Marco G; Tinazzi I; Possemato N; Macchioni P; McConnell R; McGonagle D; Iagnocco A; Zabotti A
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34204773
    [TBL] [Abstract][Full Text] [Related]  

  • 138. In Patients with Early Peripheral Psoriatic Arthritis Baseline C-Reactive Protein, Pain and Ultrasound-Detected Synovitis Predict Subsequent Treatment with ts/bDMARDs. A Retrospective Analysis.
    Sakellariou G; Quaglini S; Bugatti S; Bobbio-Pallavicini F; Gabba V; Montecucco C
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34198963
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Ultrasound definition of enthesitis in spondyloarthritis and psoriatic arthritis: arrival or starting point?
    Filippucci E; Smerilli G; Di Matteo A; Grassi W
    Ann Rheum Dis; 2021 Nov; 80(11):1373-1375. PubMed ID: 34172503
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results.
    Smolen JS; Siebert S; Korotaeva TV; Selmi C; Bergmans P; Gremese E; Joven-Ibáñez B; Katsifis G; Noël W; Nurmohamed MT; Richette P; Sfikakis PP; de Vlam K; Theander E; Gossec L
    Ann Rheum Dis; 2021 Nov; 80(11):1419-1428. PubMed ID: 34162594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.